A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy?

Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):238-241. doi: 10.1093/ehjcvp/pvaa131.

Authors

Timo E Strandberg^{1

2}, Peter Libby³, Petri T Kovanen⁴

Affiliations

¹ University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, PO Box 340, FIN-00029 Helsinki, Finland.
² University of Oulu, Center for Life Course Health Research, Oulu, Finland.
³ Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Wihuri Research Institute, Helsinki, Finland.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Inflammatory Agents* / therapeutic use
Humans
Hypolipidemic Agents* / therapeutic use
Lipids

Substances

Anti-Inflammatory Agents
Hypolipidemic Agents
Lipids

Grants and funding

R01 HL134892/HL/NHLBI NIH HHS/United States